Searcharxiv⌕ Search

arXiv subjects

Liza Hettal

Publications and source records attributed to Liza Hettal.

2 recordsLinked to original sources

How to measure intra-physician variability in clinical decision-making?

Intra-physician prescribing variability, the probability that one physician issues discordant decisions for two patients deemed comparable on observed covariates, holds great impact in quality of care, safety and cost. However, there are no known validated measurement methods. Here, we benchmark eight methods (Euclidean, Mahalanobis, Learned-Weights, Genetic Mahalanobis, Random Forest proximity, Mutual-Information-weighted, Latent Profile Analysis and Bayesian binomial generalized linear mixed model) against a synthetic ground truth across 94 experimental conditions. Learned-Weights matching achieves the lowest mean absolute error (0.027), followed by Mutual-Information-weighted matching (0.028) and RF Proximity (0.034). All eight discordance-analysis methods preserve the physician rank ordering with high fidelity (Spearman > 0.89 versus the ground truth on the SCORE2 experiment), as long as the physician variability groups are well separated. Under a continuous-heterogeneity physician model, rank preservation degrades substantially for unsupervised methods (Spearman = [0.28, 0.35]) but is retained by supervised feature-weighted methods and the GLMM (Spearman = [0.62, 0.68]). This controlled methodological evaluation is a foundation for validation on observational prescribing data. Once validated on observational prescribing data, these evaluated open-source estimators could turn prescribing inconsistency into a routinely measurable clinician-level quality metric, systematically complementing the existing literature on between-physician variation.

stat.AP↗

Learning interpretable causal networks from very large datasets, application to 400,000 medical records of breast cancer patients

Discovering causal effects is at the core of scientific investigation but remains challenging when only observational data is available. In practice, causal networks are difficult to learn and interpret, and limited to relatively small datasets. We report a more reliable and scalable causal discovery method (iMIIC), based on a general mutual information supremum principle, which greatly improves the precision of inferred causal relations while distinguishing genuine causes from putative and latent causal effects. We showcase iMIIC on synthetic and real-life healthcare data from 396,179 breast cancer patients from the US Surveillance, Epidemiology, and End Results program. More than 90\% of predicted causal effects appear correct, while the remaining unexpected direct and indirect causal effects can be interpreted in terms of diagnostic procedures, therapeutic timing, patient preference or socio-economic disparity. iMIIC's unique capabilities open up new avenues to discover reliable and interpretable causal networks across a range of research fields.

q-bio.QM↗